Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Radiology
|
August 18, 2010
Gastroesophageal junction: structure and function as assessed by using MR imaging
Jelena Curcic, Mark Fox, Elad Kaufman, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
September 26, 2009
Effect of meal volume and calorie load on postprandial gastric function and emptying: studies under physiological conditions by combined fiber-optic pressure measurement and MRI
Monika A Kwiatek, Dieter Menne, Andreas Steingoetter, et al.
The American Journal of Gastroenterology
|
March 5, 2014
Abnormal structure and function of the esophagogastric junction and proximal stomach in gastroesophageal reflux disease
Jelena Curcic, Shammodip Roy, Alexandra Schwizer, et al.
BMJ Open Respiratory Research
|
July 17, 2023
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial
John Belperio, Tuan Nguyen, David A Lombardi, et al.
The European Respiratory Journal
|
July 2, 2021
A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19
Dave Singh, Maxim Bogus, Valentyn Moskalenko, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Radiology
|
August 18, 2010
Gastroesophageal junction: structure and function as assessed by using MR imaging
Jelena Curcic, Mark Fox, Elad Kaufman, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
September 26, 2009
Effect of meal volume and calorie load on postprandial gastric function and emptying: studies under physiological conditions by combined fiber-optic pressure measurement and MRI
Monika A Kwiatek, Dieter Menne, Andreas Steingoetter, et al.
The American Journal of Gastroenterology
|
March 5, 2014
Abnormal structure and function of the esophagogastric junction and proximal stomach in gastroesophageal reflux disease
Jelena Curcic, Shammodip Roy, Alexandra Schwizer, et al.
BMJ Open Respiratory Research
|
July 17, 2023
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial
John Belperio, Tuan Nguyen, David A Lombardi, et al.
The European Respiratory Journal
|
July 2, 2021
A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19
Dave Singh, Maxim Bogus, Valentyn Moskalenko, et al.
Page
of 1